1. Home
  2. LOOP vs TLSA Comparison

LOOP vs TLSA Comparison

Compare LOOP & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

HOLD

Current Price

$1.36

Market Cap

62.8M

Sector

Industrials

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.25

Market Cap

155.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOOP
TLSA
Founded
2010
2013
Country
Canada
United Kingdom
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.8M
155.2M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
LOOP
TLSA
Price
$1.36
$1.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
46.4K
129.0K
Earning Date
01-14-2026
05-06-2025
Dividend Yield
N/A
N/A
EPS Growth
27.27
N/A
EPS
N/A
N/A
Revenue
$10,889,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$174.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7016.99
N/A
52 Week Low
$0.88
$0.73
52 Week High
$2.29
$2.60

Technical Indicators

Market Signals
Indicator
LOOP
TLSA
Relative Strength Index (RSI) 56.23 44.40
Support Level $1.17 $1.27
Resistance Level $1.47 $1.59
Average True Range (ATR) 0.09 0.10
MACD -0.00 0.00
Stochastic Oscillator 58.36 30.00

Price Performance

Historical Comparison
LOOP
TLSA

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

Share on Social Networks: